Sun Pharma Advanced Research Company Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Tube Investments of India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Aban Offshore Limited has informed the Exchange regarding NOTICE OF EGM ON 31.01.2022.
Mahanagar Gas Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Bata India Limited has informed the Exchange about Loss of Share Certificates
IFB Agro Industries Limited has informed the Exchange regarding Intimation to holder of physical securities pursuant to Regulation 30 of SEBI LODR, Regulations, 2015,.
Bharti Airtel Limited has informed the Exchange regarding Option of conversion of the interest on deferred spectrum and AGR dues into equity.
Natco Pharma Limited has informed the Exchange regarding a press release dated January 07, 2022, titled NATCO Pharma Limited has been awarded Corporate Governance Award.
Lupin Limited has informed the Exchange regarding a press release dated January 07, 2022, titled Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India..
APL Apollo Tubes Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on February 08, 2022

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.